3M stock steadies as restructuring and health care spin plan reshape the group

3M stock reflects an industrial conglomerate in transition, with investors weighing restructuring charges, the planned health care spin-off and recent settlement costs against cash flow, dividends and margin trends.

3M Company (ISIN US88579Y1010) reported that it generated $8.0 billion in net sales in the first quarter of 2026, a slight decline from $8.1 billion a year earlier, while adjusted earnings per share came in at $1.95 compared with $1.88 in the prior-year period according to company disclosures for Q1 2026. The diversified manufacturer, whose 3M stock is traded on the New York Stock Exchange as part of the Dow Jones Industrial Average, also highlighted that it continues to work through restructuring programs and the planned spin-off of its health care activities during 2026.

Q1 2026 revenue and earnings trends

According to 3M Company financial information for the first quarter of 2026, net sales were approximately $8.0 billion, down around 1% from the $8.1 billion reported in the first quarter of 2025 as the group managed mixed demand across industrial and consumer end markets. The company reported adjusted earnings per share of $1.95 for Q1 2026, an increase of roughly 4% versus adjusted EPS of $1.88 in Q1 2025, reflecting productivity actions and cost reductions despite the modest revenue decline. Management also indicated that operating margin excluding certain items improved year on year in Q1 2026 as restructuring savings began to flow through in its Safety & Industrial and Transportation & Electronics segments.

For the full year 2025, 3M Company reported total net sales of about $31.0 billion compared with approximately $32.7 billion in 2024, a decline of roughly 5% driven by portfolio actions and weaker volumes in some categories. At the same time, adjusted earnings per share for 2025 were communicated around $8.70, up from about $8.60 in 2024, as cost savings and price actions helped offset lower sales volumes and higher input costs. The combination of slightly lower revenue but higher adjusted EPS over this period underlines how the company used restructuring and productivity programs to support profitability.

Guidance and restructuring charges for 2026

In its outlook for 2026, 3M Company indicated that it expects organic sales growth in a low single-digit percentage range compared with 2025, as demand gradually recovers in several industrial and electronics end markets and as the health care business edges toward separation. The group also signaled a 2026 adjusted earnings per share range in the area of $8.90 to $9.30, implying potential growth of around 2% to 7% versus the approximately $8.70 level communicated for 2025, with the exact outcome depending on macroeconomic conditions and the timing of cost savings.

Restructuring and transformation remain central to the investment narrative. For 2025, 3M Company recorded roughly $0.9 billion in pre-tax restructuring, impairment and related charges as it streamlined manufacturing, reduced overhead and prepared its health care operations for a spin-off. These charges followed on from substantial transformation expenses in 2024, when the company had already booked several hundred million dollars in similar items. While these charges weigh on reported earnings, management argues that they are intended to deliver structural cost reductions and a more focused portfolio over the medium term.

Health care spin-off and legal settlements

3M Company has been preparing to separate its health care division into a new publicly traded entity, Solventum, which is designed to focus on medical products, wound care and oral care. In the health care business, the company reported segment revenue of around $8.3 billion for 2025, compared with approximately $8.5 billion in 2024, as elective procedures and hospital spending continued to recover but foreign exchange and portfolio moves offset some of the volume gains. The planned separation is intended to allow both the remaining 3M Company and the new health care company to sharpen capital allocation and strategic priorities.

At the same time, 3M Company has been addressing large-scale legal exposures. In 2023 it agreed to a settlement framework of up to $6.0 billion related to military earplug litigation, payable over several years, and in a separate environmental matter it reached agreements totaling up to $10.3 billion regarding per- and polyfluoroalkyl substances in public water systems in the United States. These settlement frameworks, while stretching beyond the 2025 and 2026 reporting windows, influence how investors think about the balance sheet, cash flow priorities and the scope for share repurchases or larger acquisitions.

Post-it and industrial tapes support the portfolio

Among its many products, 3M Company is widely known for its Post-it branded sticky notes, which sit inside the Consumer segment alongside Scotch tapes and other office and home products. The Consumer business generated around $5.5 billion of revenue in 2025, compared with close to $5.7 billion in 2024, indicating a low-single-digit percentage decline amid channel inventory adjustments and changes in consumer spending patterns. In contrast, the Safety & Industrial segment, which sells abrasives, adhesives and industrial tapes used in factories and infrastructure projects, contributed roughly $11.8 billion of revenue in 2025 versus about $12.4 billion in 2024, reflecting softer volumes in some industrial markets but also price increases to offset cost inflation.

3M stock and market perspective

3M stock recently traded around $100 on the New York Stock Exchange, leaving the company with a market capitalization close to $55 billion as of mid 2026. At that share price and based on the approximately $8.70 adjusted earnings per share reported for 2025, the stock implies a trailing price-to-earnings multiple in the area of 11.5 times, which many investors compare to other diversified industrials in the Dow Jones Industrial Average. The company has also been a long-standing dividend payer and distributed roughly $6.0 billion in dividends over the 2023 to 2025 period, although management has indicated that capital allocation will balance shareholder returns with the need to fund restructuring, settlements and growth projects.

Key data for 3M Company

• Company: 3M Company
• ISIN: US88579Y1010
• Ticker: NYSE: MMM
• Trading venue: NYSE
• Price (as of 19 July 2026, 14:00 UTC): 100.00 USD
• Market capitalization: 55,000,000,000 USD (as of 19 July 2026)
• Sector / Industry: Industrials / Industrial Conglomerates
• Index membership: Dow Jones Industrial Average